企業を読み込み中
IDXXIdexx Laboratories Inc.$55BA+売上構成比はyear ended December 31, 2025の推計であり、提出された報告書の数字ではありません。
Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.
DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.
Thermo Fisher sells products and services to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies, and industrial customers. Its products include research supplies, instruments for analyzing samples, and diagnostic tests; its services include clinical-trial work and manufacturing medicines for customers. In the second quarter of 2026, management said customer demand had strengthened across its major markets.
Thermo Fisher Scientific Inc. 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
The themes Thermo Fisher Scientific is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$699.56-2.5%11月12日 終値
2026年9月26日までの数値（2026年10月30日提出の10-Qより）
Thermo Fisher sells laboratory supplies, scientific instruments, diagnostic tests, and services for developing and making medicines.
Grade A+
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Thermo Fisher Scientific Inc. の評価履歴 41 四半期のうち 2 四半期を表示しています。 残る 39 四半期は 2016年11月 まで遡ります。
